IL44304A - 3-benzyl-pyrido(3,4-e)-as-triazine derivatives and their preparation - Google Patents

3-benzyl-pyrido(3,4-e)-as-triazine derivatives and their preparation

Info

Publication number
IL44304A
IL44304A IL44304A IL4430474A IL44304A IL 44304 A IL44304 A IL 44304A IL 44304 A IL44304 A IL 44304A IL 4430474 A IL4430474 A IL 4430474A IL 44304 A IL44304 A IL 44304A
Authority
IL
Israel
Prior art keywords
benzylpyrido
triazine
compound
hydrochloride
dihydro
Prior art date
Application number
IL44304A
Other languages
Hebrew (he)
Other versions
IL44304A0 (en
Original Assignee
Morton Norwich Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morton Norwich Products Inc filed Critical Morton Norwich Products Inc
Publication of IL44304A0 publication Critical patent/IL44304A0/en
Publication of IL44304A publication Critical patent/IL44304A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The titled compounds are effective antifungal agents adapted to be combined in pharmaceutical forms for use in the eradication of fungus infections. [US3883526A]

Description

derivatives and This invention is concerned with the compounds and These compounds are effective antifungal and lower derivatives thereof are known from Patent Specification The in these known compounds are to lower alkyl and lower carboalkoxy and thus could not have suggested the specific according to the present The compounds of the present invention are readily prepared in accordance with the following EXAMPLE I 3 Hydrochloride Ethyl Hydrochloride To a solution of 91 g of in 600 of phenol was added 62 g of ethyl carbazate at using mechanical The reaction was exothermic over ca 5 with a temperature rise to The reaction solution was heated on the v steam bath for cooled to and added to of anhydrous After standing at room temperature for ca 10 the supernatant solution was and the resultant amorphous solid was washed twice with anhydrous The solid was treated with 500 ml of heating on the steam bath with affording a light crystalline Upon cooling in an ice bath for ca 10 the initial product was washed well With isopropanol and in a vacuum dessicator 55 g The product was recrystallized from 700 ml of 40 for O Hydrochlorldo Ά solution of 87 g mole of in 520 of concentrated HC1 was heated to dryness over 23 hr on a steam The yellow residue was slurried in 200 ml of refluxed for 20 and filtered The red crystalline solid was washed with 100 ml of 200 ml of and 39 g The crude product was recrystalized from 1050 ml of washed with five portions of 250 ml of and 24 g for Hydrochloride A 22 g portion of was slurried in 170 ml of treated with g of and subjected to hydrogenation at 50 hydrogen uptake was 30 lb in 4 The reduction mixture was cooled for 2 hr and The product plus catalyst was washed with three portions of and 17 g This procedure was repeated more to give a combined total of 34 g of the product plus The crude 34 was recrystallized from of methanol washed with 170 ml of 300 ml of ether and 23 g for y pyr o Hydrochloride A mixture of g of and 60 g of acetic acid was heated in a bath for 2 It was then cooled and shaken with a mixture of ml of chloroform and 400 ml of water layer was washed with 300 ml portions of chloroform and evaporated to dryness under The resulting red oil was dissolved in 400 ml of absolute A precipitate formed which was filtered and washed with ethanol and then 30 This was recrystallized from anhydrous methanol to yield for 13 12 4 EXAMPLE II To a solution of 20 g of the compound of Example I in 400 ml of water and 100 ml of ethanol was added a solution of g of in 50 ml of Manganese dioxide was added and the reaction was stirred for The reaction was filtered and the residue was washed with chloroform until the washings were colorless The chloroform layer was washed with filtered through anhydrous and to 16 g for 13 10 4 The compounds of this invention are potent antifungal are capable in small concentration of inhibiting the growth of pathogenic fungi such as Candida albicans and Mlcrosoorum canis Such capabilities are represented in the table herebelow which reflects results secured in the commonly used in antifungal test employing dextrose agar as the medium supportive of fungal growth and measuring the amount of inhibition of such growth in millimeters over a period of eight insufficientOCRQuality

Claims (5)

Diameter of Zone of Inhibition in mm at Days *Conc in C. albicans M. canis Compound mc /ml 2 4 6 8 4 6 0 Example I 2000 33 32 52 Example II 1860 33 33 10 * The diluent carrier for the compound in this test is 50% ethanol which exhibits no antifungal activity. A noteworthy characteristic of the compounds of this invention is their lack of irritation to the skin. When applied daily in the form of a suspension at concentrations up to 4% in a vehicle of aqueous methyl cellulose* no skin irritation was observed over a period of three days. For convenience in administration the compounds of this invention can be compounded in various pharmaceutical forms such as ungents, solutions, suspensions, powders and sprays using readily available and commonly used excipients with which there is no incompatibility. What Is claimed is;
1. Λ compound selected from the group consisting of l,2-dihydro-3-benzylpyrido [3,4-e]-as-triazine hydrochloride and 3-benzylpyrido[3,4-e]-as-triazine.
2. The compound l,2-dihydro-3-benzylpyrido- [3,4-e]-as-triazine hydrochloride .
3. The compound 3-benzylpyrido(3,4-e]-as-triazine.
4. The method of preparing l,2-dihydro-3-benzylpyrido(3,4-e]-as-triazine hydrochloride which consists in reacting 3-amino-4-hydrazinopyridine hydrochloride and phenylacetic acid.
5. The method of preparing 3-benzylpyrido[3,4-e]-as-triazine which consists in oxidizing l,2-dihydro-3-ben.-!ylpyrido[3,4-e]-as-triazine hydrochloride with manganese dioxide.
IL44304A 1973-06-06 1974-02-27 3-benzyl-pyrido(3,4-e)-as-triazine derivatives and their preparation IL44304A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US367500A US3883526A (en) 1973-06-06 1973-06-06 3-Benzylpyrido {8 3,4-e{9 -as-triazine and 1,2-dihydro-3-benzylpyrido{8 3,4-e{9 -as-triazine hydrochloride

Publications (2)

Publication Number Publication Date
IL44304A0 IL44304A0 (en) 1974-05-16
IL44304A true IL44304A (en) 1977-05-31

Family

ID=23447426

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44304A IL44304A (en) 1973-06-06 1974-02-27 3-benzyl-pyrido(3,4-e)-as-triazine derivatives and their preparation

Country Status (13)

Country Link
US (1) US3883526A (en)
JP (1) JPS5019772A (en)
AU (1) AU473797B2 (en)
BE (1) BE816006A (en)
CH (1) CH591479A5 (en)
DE (1) DE2427382A1 (en)
DK (1) DK302274A (en)
FR (1) FR2232322B1 (en)
GB (1) GB1391900A (en)
IL (1) IL44304A (en)
NL (1) NL7403598A (en)
SE (1) SE7405655L (en)
ZA (1) ZA741277B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE409863B (en) * 1975-08-01 1979-09-10 Egyt Gyogyszervegyeszeti Gyar ANALOGICAL PROCEDURE FOR THE PREPARATION OF PYRIDO (3,4-E) -AS-TRIAZINE DERIVATIVES
DE3064301D1 (en) * 1979-10-18 1983-08-25 Interox Chemicals Ltd Magnesium salts of peroxycarboxylic acids, processes for their preparation and their use as bleaching agents in washing compositions, and processes
JPS6336085A (en) * 1986-07-30 1988-02-16 Taiko Kikai Kogyo Kk Screw type vacuum pump

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597427A (en) * 1969-01-13 1971-08-03 American Cyanamid Co 1,2-dihydropyrido(3,4-e)-as-triazines

Also Published As

Publication number Publication date
AU473797B2 (en) 1976-07-01
IL44304A0 (en) 1974-05-16
GB1391900A (en) 1975-04-23
FR2232322A1 (en) 1975-01-03
DE2427382A1 (en) 1975-01-02
ZA741277B (en) 1975-10-29
BE816006A (en) 1974-12-06
AU6884674A (en) 1975-11-13
FR2232322B1 (en) 1977-09-09
DK302274A (en) 1975-02-03
SE7405655L (en) 1974-12-09
NL7403598A (en) 1974-12-10
JPS5019772A (en) 1975-03-01
CH591479A5 (en) 1977-09-15
US3883526A (en) 1975-05-13

Similar Documents

Publication Publication Date Title
FI91638B (en) Process for the preparation of tetracyclic antidepressants
IL44304A (en) 3-benzyl-pyrido(3,4-e)-as-triazine derivatives and their preparation
US4794197A (en) All-cis-1,3,5-triamino-2,4,6,-cyclohexanetriol derivatives, their use, processes for their preparation and pharmaceutical preparations containing them
IL44305A (en) 3-phenoxymethyl-pyrido(3,4-e)-as-triazine derivatives and their preparation
Fales et al. Use of benzene in separating aromatic methoxyl bands in nuclear magnetic resonance spectroscopy
US4115407A (en) N-Benzyl-4-chromanamines
ES435497A1 (en) Dihydroquinoline derivatives
US4734506A (en) 4-amino-3-imidazolin-2-one
US4409389A (en) Preparation of imidazoles
DE2625000A1 (en) 4.5 DIHYDROTETRAZOLO SQUARE CLAMP ON 1.5 ANGLE BRACKET FOR QUINOXALINE AND THE METHOD OF MANUFACTURING IT
EP0000727B1 (en) 3-(4-(1,3-diazacycloalkene-2-yl)-phenyl)-1,2-benzisothiazoles, process for their preparation and medicaments containing them.
DD201675A5 (en) PROCESS FOR THE PREPARATION OF CIMETIDINE
US3873542A (en) 3-Amino-as-triazino{8 6,5-c{9 quinoline and its 1-oxide, and a process for the preparation thereof
US4018792A (en) 5-Cyano-thiophen-2-aldehyde-isothiosemicarbazones and process for preparing them
CN110204511B (en) Thymol amino alcohol and preparation method and application thereof
SU852173A3 (en) Method of preparing 5,6-dihydroimidazo(5,1-a)isoquinoline derivatives or their salts
US4095023A (en) 6-methoxy-n-vanillylidene-4-chromanamine
Garraway 759. Derivatives of dithiocarbamic acids
US4182877A (en) Substituted anthranilates
JP2577216B2 (en) Benzyl isoquinoline derivative
JPS646197B2 (en)
Kumari et al. Synthesis of ternary metal complexes of bivalent metal ions with benzimidazole derivative and their antimicrobial studies
US3433789A (en) S-benzoyloxymethyl-thiamines
JP2577215B2 (en) Benzyl isoquinoline derivative
EP0000750A1 (en) 1,2-Benzisothiazoles and process for their preparation